
Medical Device Cybersecurity Standards
The 14 medical device cybersecurity standards FDA reviewers expect - ISO 14971, IEC 62304/81001-5-1, AAMI TIR57/TIR97, UL 2900 - mapped to SPDF artifacts.
Read articleEvery article in our archive in FDA.
Looking for a quick answer instead? The FDA medical device cybersecurity FAQ covers Section 524B scope, SBOMs, threat models, CR515 and GMLP, deficiencies, and postmarket duties.
Showing 12 of 54 articles in FDA · Page 4 of 5

The 14 medical device cybersecurity standards FDA reviewers expect - ISO 14971, IEC 62304/81001-5-1, AAMI TIR57/TIR97, UL 2900 - mapped to SPDF artifacts.
Read article
What a 510(k) really costs: FDA user fees, small business discounts, testing, cybersecurity work and consultant spend, plus how De Novo and PMA costs compare.
Read article
Search the FDA 510(k), De Novo, and PMA databases for cybersecurity precedent, product codes, and predicate devices before a Section 524B premarket filing.
Read article
Medical device cybersecurity checklist covering design, development, testing, submission, and postmarket phases, with the evidence FDA reviewers expect.
Read article
RTOS security explained for medical devices: attack surface, isolation controls, secure boot, SBOM, and what the FDA expects documented.
Read article
Modular PMA Submission explained for medical device manufacturers, definition, FDA context, and what teams must document for 2026 submissions.
Read article
Medical device authentication and access control: what the FDA's Feb 2026 guidance expects for credentials, privilege levels, biometrics, and audit logs.
Read article
FDA 2026 medical device cybersecurity labeling requirements: interfaces, SBOM, secure configuration, update/patch steps - and mistakes that cause review.
Read article
How IVD cybersecurity differs from therapeutic devices: LIS/HL7 interfaces, analyzer OS risk, service access, QC data integrity, and submission evidence.
Read article
How MedTech teams should identify, triage, and document VxWorks RTOS vulnerabilities (URGENT/11 and beyond) for FDA Section 524B premarket and postmarket.
Read article
CBER (Center for Biologics Evaluation and Research) explained for medical device manufacturers, definition, FDA context, and what teams must document for 2026 submissions.
Read article
The essential role of the Center for Devices and Radiological Health (CDRH) in ensuring the safety, effectiveness, and cybersecurity of medical devices.
Read article30-minute strategy session. No cost, no commitment - just answers from people who've shipped 275+ devices supported.